Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01879098 · ClinicalTrials.gov registry record · Phase 1
The Effect of 3 Probiotic Strains on Bile Acids, Satiety, and Inflammation
A Phase 1 study, sponsored by University of Florida.
- Completed
- Registry status
- Phase 1
- Development phase
- 155
- Enrollment target
NCT01879098: Completed Phase 1 study, sponsored by University of Florida.
NCT01879098 is a Phase 1 study that has completed, run by University of Florida. The registered enrollment target is 155 participants, above the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (158% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01879098, a Phase 1 study, has completed, sponsored by University of Florida.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 155 participants
- Enrollment target
Study Summary
The purpose of this research study is to determine whether a probiotic can change the way bile is used by the body. The investigators will also look at the effect of the probiotic on your intestinal health.
Primary Outcome
Levels of deconjugated bile acids in the stool and in the blood will be compared between treatment periods for each subject/group.
Interventions
- DIETARY_SUPPLEMENT Placebo
- DIETARY_SUPPLEMENT Bifidobacterium animalis
- DIETARY_SUPPLEMENT Lactobacillus plantarum
- DIETARY_SUPPLEMENT Probiotic: Bacillus subtilis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 155 participants |
| Start Date | 2013-08 |
| Est. Completion | 2014-06 |
| Phase | Phase 1 |
What the finished NCT01879098 record still lists
NCT01879098 is an interventional study that assigns participants to a tested intervention. The registered 155 participants enrollment target is mid-sized for trials with a published cap, above the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (158% higher).
The record links to 0 conditions, and to 4 interventions - of which Placebo is the first listed.
NCT01879098 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01879098 about?
NCT01879098 is a clinical study titled "The Effect of 3 Probiotic Strains on Bile Acids, Satiety, and Inflammation". The purpose of this research study is to determine whether a probiotic can change the way bile is used by the body. The investigators will also look at the effect of the probiotic on your intestinal health.
What is the current status of trial NCT01879098?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 155 participants. The study started on 2013-08. Estimated completion is 2014-06.
What interventions are being tested in trial NCT01879098?
The interventions under investigation include: Placebo (DIETARY_SUPPLEMENT), Bifidobacterium animalis (DIETARY_SUPPLEMENT), Lactobacillus plantarum (DIETARY_SUPPLEMENT), Probiotic: Bacillus subtilis (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT01879098?
This trial is sponsored by University of Florida, which has 1,106 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01879098's enrollment target sits among peer trials
155 352nd of 2000 higher than 1,645 of 2,000 other Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03223610 · 155 participants · Phase 1
Venetoclax, Ibrutinib, Prednisone, Obinutuzumab, and Revlimid (ViPOR) in Relapsed/Refractory B-cell Lymphoma
- NCT05072483 · 155 participants
Natural History Study of CADASIL
- NCT05086497 · 155 participants · NA
WBSI Guided Personalized Delivery of TTFields
- NCT05412069 · 155 participants · NA
Trial to Evaluate Fecobionics in Fecal Incontinence (FI) (NORMAL and ABNORMAL-FI)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia